Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
View ORCID ProfileYohei Funakoshi, View ORCID ProfileKimikazu Yakushijin, View ORCID ProfileGoh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, Taku Nose, Shinya Ohata, Yoshiaki Nagatani, Taiji Koyama, Akihito Kitao, Meiko Nishimura, Yoshinori Imamura, View ORCID ProfileNaomi Kiyota, Kenichi Harada, Yugo Tanaka, Yasuko Mori, View ORCID ProfileHironobu Minami
doi: https://doi.org/10.1101/2021.10.25.21265324
Yohei Funakoshi
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Kimikazu Yakushijin
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Goh Ohji
2Division of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Wataru Hojo
3R&D, Cellspect Co., Ltd., Morioka, Japan
Hironori Sakai
3R&D, Cellspect Co., Ltd., Morioka, Japan
Ryo Takai
4Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Taku Nose
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Shinya Ohata
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Yoshiaki Nagatani
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Taiji Koyama
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Akihito Kitao
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Meiko Nishimura
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Yoshinori Imamura
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Naomi Kiyota
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
5Cancer Center, Kobe University Hospital, Kobe, Japan
Kenichi Harada
6Division of Urology, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Yugo Tanaka
7Division of Thoracic Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Yasuko Mori
8Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan
Hironobu Minami
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
5Cancer Center, Kobe University Hospital, Kobe, Japan
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted October 25, 2021.
Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, Taku Nose, Shinya Ohata, Yoshiaki Nagatani, Taiji Koyama, Akihito Kitao, Meiko Nishimura, Yoshinori Imamura, Naomi Kiyota, Kenichi Harada, Yugo Tanaka, Yasuko Mori, Hironobu Minami
medRxiv 2021.10.25.21265324; doi: https://doi.org/10.1101/2021.10.25.21265324
Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, Taku Nose, Shinya Ohata, Yoshiaki Nagatani, Taiji Koyama, Akihito Kitao, Meiko Nishimura, Yoshinori Imamura, Naomi Kiyota, Kenichi Harada, Yugo Tanaka, Yasuko Mori, Hironobu Minami
medRxiv 2021.10.25.21265324; doi: https://doi.org/10.1101/2021.10.25.21265324
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (662)
- Anesthesia (177)
- Cardiovascular Medicine (2583)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12112)
- Forensic Medicine (10)
- Gastroenterology (751)
- Genetic and Genomic Medicine (4012)
- Geriatric Medicine (377)
- Health Economics (670)
- Health Informatics (2591)
- Health Policy (993)
- Hematology (357)
- HIV/AIDS (828)
- Medical Education (397)
- Medical Ethics (107)
- Nephrology (425)
- Neurology (3783)
- Nursing (207)
- Nutrition (560)
- Oncology (1971)
- Ophthalmology (574)
- Orthopedics (233)
- Otolaryngology (301)
- Pain Medicine (248)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1093)
- Primary Care Research (442)
- Public and Global Health (6454)
- Radiology and Imaging (1371)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (336)
- Surgery (434)
- Toxicology (51)
- Transplantation (185)
- Urology (165)